In this situation, almost all the studies have been carried out on in vivo mouse model of DSS-induced colitis leading to the conclusion that TREM-1 inhibition reduces colitis and tumor development within animal’s colon (21, 22). This evidence concerns the gene TREM1 and neoplasm.